Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
US7902361B2 · kind B2 · utility
4Cited by
9References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 2006 |
| Grant date | Mar 8, 2011 |
| Priority date | — |
| Expiry date | Feb 14, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I, or pharmaceutically acceptable salts thereof,wherein R1 and R5 are each independently H, C(ORj′) or a hydrocarbyl group optionally substituted by one or more R6 groups; Further aspects of the invention relate to pharmaceutical compositions comprising such compounds, and their use in the preparation of a medicament for treating one or more of the following: a proliferative disorder, a viral disorder, a CNS disorder, a stroke, alopecia and diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.